178 related articles for article (PubMed ID: 15917510)
21. Toxoplasma gondii purine nucleoside phosphorylase biochemical characterization, inhibitor profiles, and comparison with the Plasmodium falciparum ortholog.
Chaudhary K; Ting LM; Kim K; Roos DS
J Biol Chem; 2006 Sep; 281(35):25652-8. PubMed ID: 16829527
[TBL] [Abstract][Full Text] [Related]
22. Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase.
Darling JA; Sullivan WJ; Carter D; Ullman B; Roos DS
Mol Biochem Parasitol; 1999 Sep; 103(1):15-23. PubMed ID: 10514077
[TBL] [Abstract][Full Text] [Related]
23. Cloning, characterization and validation of inosine 5'-monophosphate dehydrogenase of Babesia gibsoni as molecular drug target.
Cao S; Aboge GO; Terkawi MA; Zhou M; Luo Y; Yu L; Li Y; Goo Y; Kamyingkird K; Masatani T; Suzuki H; Igarashi I; Nishikawa Y; Xuan X
Parasitol Int; 2013 Apr; 62(2):87-94. PubMed ID: 23142571
[TBL] [Abstract][Full Text] [Related]
24. Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.
Umejiego NN; Li C; Riera T; Hedstrom L; Striepen B
J Biol Chem; 2004 Sep; 279(39):40320-7. PubMed ID: 15269207
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
Prosise GL; Wu JZ; Luecke H
J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
[TBL] [Abstract][Full Text] [Related]
26. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells.
Hodges SD; Fung E; McKay DJ; Renaux BS; Snyder FF
J Biol Chem; 1989 Oct; 264(30):18137-41. PubMed ID: 2572589
[TBL] [Abstract][Full Text] [Related]
27. Kinetic mechanism of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase.
Digits JA; Hedstrom L
Biochemistry; 1999 Feb; 38(8):2295-306. PubMed ID: 10029522
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of a novel histone acetyltransferase homologue from the protozoan parasite Toxoplasma gondii reveals a distinct GCN5 family member.
Sullivan WJ; Smith CK
Gene; 2000 Jan; 242(1-2):193-200. PubMed ID: 10721712
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a leucine aminopeptidase from Toxoplasma gondii.
Jia H; Nishikawa Y; Luo Y; Yamagishi J; Sugimoto C; Xuan X
Mol Biochem Parasitol; 2010 Mar; 170(1):1-6. PubMed ID: 19931316
[TBL] [Abstract][Full Text] [Related]
30. The apicomplexan parasite Toxoplasma gondii generates pyridoxal phosphate de novo.
Knöckel J; Müller IB; Bergmann B; Walter RD; Wrenger C
Mol Biochem Parasitol; 2007 Mar; 152(1):108-11. PubMed ID: 17222923
[No Abstract] [Full Text] [Related]
31. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of two plant-like enolases with distinct enzymatic and antigenic properties during stage conversion of the protozoan parasite Toxoplasma gondii.
Dzierszinski F; Mortuaire M; Dendouga N; Popescu O; Tomavo S
J Mol Biol; 2001 Jun; 309(5):1017-27. PubMed ID: 11399076
[TBL] [Abstract][Full Text] [Related]
33. Isolation and molecular characterization of the bifunctional hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene from Toxoplasma gondii.
Pashley TV; Volpe F; Pudney M; Hyde JE; Sims PF; Delves CJ
Mol Biochem Parasitol; 1997 May; 86(1):37-47. PubMed ID: 9178266
[TBL] [Abstract][Full Text] [Related]
34. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
35. Characterization of human type I and type II IMP dehydrogenases.
Carr SF; Papp E; Wu JC; Natsumeda Y
J Biol Chem; 1993 Dec; 268(36):27286-90. PubMed ID: 7903306
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the novel Trypanosoma brucei inosine 5'-monophosphate dehydrogenase.
Bessho T; Morii S; Kusumoto T; Shinohara T; Noda M; Uchiyama S; Shuto S; Nishimura S; Djikeng A; Duszenko M; Martin SK; Inui T; Kubata KB
Parasitology; 2013 May; 140(6):735-45. PubMed ID: 23369253
[TBL] [Abstract][Full Text] [Related]
37. The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression.
Chiang CW; Carter N; Sullivan WJ; Donald RG; Roos DS; Naguib FN; el Kouni MH; Ullman B; Wilson CM
J Biol Chem; 1999 Dec; 274(49):35255-61. PubMed ID: 10575012
[TBL] [Abstract][Full Text] [Related]
38. Characterization of two T. gondii CK1 isoforms.
Donald RG; Zhong T; Meijer L; Liberator PA
Mol Biochem Parasitol; 2005 May; 141(1):15-27. PubMed ID: 15811523
[TBL] [Abstract][Full Text] [Related]
39. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants.
Bohne W; Gross U; Ferguson DJ; Heesemann J
Mol Microbiol; 1995 Jun; 16(6):1221-30. PubMed ID: 8577255
[TBL] [Abstract][Full Text] [Related]
40. Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus.
Huete-Pérez JA; Wu JC; Whitby FG; Wang CC
Biochemistry; 1995 Oct; 34(42):13889-94. PubMed ID: 7577983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
